Antipsychotics. BMF 84 - Antipsychotics

Similar documents
Formulary Item Restrictions and/or Advice Site availability

Antidepressants. BMF 83 - Antidepressants

Antipsychotics. This factsheet covers -

This factsheet covers:

Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses

Antipsychotic Medication: Monitoring Side Effects

1 Chapter 1 A Review on Antipsychotic Drug Substances and. Importance of Alternate Synthetic Approaches to Drug Substances

South London and the Maudsley NHS Foundation Trust Medicines Formulary

Mental Health Medicines Management Pilot. Community Pharmacy. High Dose Antipsychotic Screening, Education & Advice Service

Antipsychotic Medication

Antipsychotics. Neuroleptics/ Major Tranquilizers. Hiwa K. Saaed, PhD Pharmacology & Toxicology /5/18 1

Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

What Team Members Other Than Prescribers Need To Know About Antipsychotics

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Antidepressants. Dr Malek Zihlif

The routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

National Center for Mental Health

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Special Project. National Mental Health Benchmarking Project Forensic Forum. Seclusion Medication Audit

Chapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses

Treat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering

SHARED CARE GUIDELINE

National Center for Mental Health

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia

ANTIPSYCHOTICS/ NEUROLEPTICS

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009

CHLORPROMAZINE EQUIVALENTS VERSUS DEFINED DAILY DOSES: HOW TO COMPARE ANTIPSYCHOTIC DRUG DOSES?

Document Title Antipsychotics Prescribing Guidelines for Schizophrenia

Providing an overview of antipsychotic drugs: is schizophrenia a psychiatric challenge?

Chapter 161 Antipsychotics

Method. NeuRA First versus second generation antipsychotics August 2016

Joint Formulary for Psychotropic Medication.

This document has been produced in collaboration with the Lancashire Commissioning Support Unit

Modern Treatments. Modern Treatments for Schizophrenia

Antipsychotic Prescribing Audit:

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Providing an overview on antipsychotics: schizophrenia a psychiatric challenge? A 2017 Update

AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET

Antipsychotic Medications Age and Step Therapy

Supplementary Online Content

University of Groningen. Pharmacy data as a tool for assessing antipsychotic drug use Rijcken, Claudia

See Important Reminder at the end of this policy for important regulatory and legal information.

Sponsored by the Neuroscience Education Institute Additionally sponsored by the American Society for the Advancement of Pharmacotherapy

Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011)

The antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in

MO Medicaid Foster Care Drugs FY10-FY14

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 30 November 2011

Medications and Children Disorders

TRANSPARENCY COMMITTEE

Schizophrenia and Antipsychotic Medications

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues

Use of Antipsychotics in General Practice

Michael J. Bailey, M.D. OptumHealth Public Sector

Chapter 4 ~ Central nervous system

High Dose Antipsychotic Therapy (HDAT) guideline

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

See Important Reminder at the end of this policy for important regulatory and legal information.

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08.

Safe transfer of prescribing guidance

Woman Looking Through Opera Glasses, oil on cardboard c , Edgar Degas, Galerie Neue Meister, Dresden.

Extrapyramidal Symptoms Associated with Antipsychotic Use

Proposed Changes to Existing Measure for HEDIS : Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA)

Charles P. Samenow, MD, MPH Department of Psychiatry George Washington University

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Antipsychotic Use in the Elderly

Table of Contents. 1.0 Policy Statement...1

CLOZAPINE. Clozapine, (trade name Clopine and Clozaril in Australia) is a second generation atypical antipsychotic agent.

NEUROPSYCHIATRY DSM (PYDI 0416) FALL, 1999 MEDICINAL CHEMISTRY OF ANTIPSYCHOTICS DR. RILEY A. INTRODUCTION

Thorazine 25 Mg Iv chlorpromazine hcl 50 mg chlorpromazine 10 mg chlorpromazine tablets uses chlorpromazine tablets ip 100mg thorazine ivpb

MMG012 GUIDELINES FOR THE USE OF HIGH DOSE ANTIPSYCHOTIC MEDICATION

Treatment of Schizophrenia Appendix Three Page 1 of 8

Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065

Guidelines on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults

Atypical Antipsychotic Use for the Behavioural and Psychological Symptoms of Dementia in the Elderly

GUIDELINES FOR THE USE OF ARIPIPRAZOLE LONG-ACTING INJECTION (ABILIFY MAINTENA)

High Dose Antipsychotic Therapy (HDAT) guideline

Psychotropic Medication Use in Dementia

TERAPI FARMAKOLOGI ANTIPSIKOTIK

CHAPTER 3. Schizophrenia and Antipsychotic Treatment

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

Drug Utilization Pattern of Antipsychotics in Norway:

Prescription of High Dose Antipsychotic Medication

ANTIPSYCHOTICS: Clinical Pharmacology

Use of Psychotropic Medications in Older Adults with Dementia!

Medicines Formulary BNF Section 4 Central Nervous System

HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE

Biological Psych Schizophrenia

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

Transcription:

Antipsychotics BMF 84 - Antipsychotics Antipsychotic medications (neuroleptics) are used for the treatment of psychosis, mainly schizophrenia and manic depression (bipolar disorder). They reduce symptoms such as hallucinations, delusions, and paranoia, and can also be used to help severe anxiety or depression. Antipsychotic medications have been available for the treatment of psychosis for over half a century. The first being chlorpromazine (Thorazine), introduced in the early 1950 s. The list now extends to over 20 different compounds. Antipsychotics act by blocking dopamine receptors in the brain and interfering with dopaminergic transmission. Side effects include movement disorders similar to Parkinson s disease, such as shaking/tremor, involuntary body movements and inner restlessness. These are referred to as extrapyramidal symptoms, and can be controlled with anticholinergic drugs such as orphenadrine and procyclidine. Other side effects include lethargy, weight gain and sexual dysfunction. Longer term there is increased risk of developing type 2 diabetes, high blood pressure, heart problems and osteoporosis. Antipsychotics are may be classified as typical or atypical, or first and second generation respectively. Typical antipsychotics include; Chlorpromazine, Haloperidol, Pimozide, Trifluoperazine, and Sulpiride. Atypical include; Amisulpride, Aripiprazole, Clozapine, Olanzapine, Quetiapine and Risperidone. Atypical antipsychotics, are useful in patients that do not respond to treatment with typical antipsychotics. They cause less extrapyramidal side effects and have a greater efficacy to treat negative symptoms. Atypical antipsychotics also block dopamine, but to a lesser degree than the older drugs. They also work on serotonin. Some antipsychotics are available in depot form, i.e. Haloperidol decanoate, Flupenthixol decanoate, Fluphenazine decanoate, Pipothiazine palmitate and Zuclopenthixol decanoate. These are injected into muscle every 2 to 4 weeks and release slowly over time. This prevents patients forgetting to take their medication. www.chiron.no E-mail: sales@chiron.no Tel.: +47 73 87 44 90 Fax.: +47 73 73 87 44 99 BMF 84 p.1/6, 11_16

Chiron offer a range of antipsychotic reference materials and associated internal standards; Catalogue No. Description Cas No. Concentration Solvent Volume Aripiprazole (Abilify) 2305.23-100-AN Aripiprazole 129722-12-9 100 µg/ml acetonitrile 1 ml 2305.23-K-AN Aripiprazole 129722-12-9 1000 µg/ml acetonitrile 1 ml 2305.23-10MG Aripiprazole 129722-12-9 neat neat 10 mg 2305.23-25MG Aripiprazole 129722-12-9 neat neat 25 mg 9653.23-100-AN Aripiprazole-d8 (butyl-d8) 1089115-04-7 100 µg/ml acetonitrile 1 ml 11004.23-K-ME Amisulpride (Solian) Dehydroaripiprazole hydrochloride (Aripiprazole Impurity E) 1008531-60-9 1000 µg base/ml methanol 1 ml 10349.17-10MG (+/-)-Amisulpride 71675-85-9 neat neat 10 mg 10349.17-50MG (+/-)-Amisulpride 71675-85-9 neat neat 50 mg 10349.17-100MG (+/-)-Amisulpride 71675-85-9 neat neat 100 mg Chlorpromazine (Largactil) 10350.17-K-ME Chlorpromazine hydrochloride 69-09-0 1000 µg base/ml methanol 1 ml 10350.17-50MG Chlorpromazine hydrochloride 69-09-0 neat neat 50 mg 10350.17-100MG Chlorpromazine hydrochloride 69-09-0 neat neat 100 mg 10841.17-100-ME Clozapine (Clozaril) Chlorpromazine-d6 oxalate (N,N-dimethyl-d6) 1276197-23-9 100 µg/ml methanol 1 ml 9275.18-100-ME Clozapine 5786-21-0 100 µg/ml methanol 1 ml 9275.18-K-ME Clozapine 5786-21-0 1000 µg/ml methanol 1 ml 9275.18-10MG Clozapine 5786-21-0 neat neat 10 mg 9275.18-25MG Clozapine 5786-21-0 neat neat 25 mg 9275.18-100MG Clozapine 5786-21-0 neat neat 100 mg 9406.18-100-ME 9406.18-K-ME 9406.18-10MG 10807.17-K-ME Clozapine-d4 (4-methylpiperazinyl-2,2,6,6-d4) Clozapine-d4 (4-methylpiperazinyl-2,2,6,6-d4) Clozapine-d4 (4-methylpiperazinyl-2,2,6,6-d4) Norclozapine (N-Desmethylclozapine) 204395-52-8 100 µg/ml methanol 1 ml 204395-52-8 1000 µg/ml methanol 1 ml 204395-52-8 neat neat 10 mg 6104-71-8 1000 µg/ml methanol 1 ml 10808.18-100-ME Clozapine N-oxide 34233-69-7 100 µg/ml methanol 1 ml 10808.18-K-ME Clozapine N-oxide 34233-69-7 1000 µg/ml methanol 1 ml Droperidol 11983.22-10MG Droperidol 548-73-2 neat neat 10 mg Flupentixol 10358.23-K-ME 10358.23-10MG Flupentixol dihydrochloride (cis+trans) Flupentixol dihydrochloride (cis+trans) 2413-38-9 1000 µg base/ml methanol 1 ml 2413-38-9 neat neat 10 mg www.chiron.no E-mail: sales@chiron.no Tel.: +47 73 87 44 90 Fax.: +47 73 73 87 44 99 BMF 84 p.2/6, 11_16

Catalogue No. Description Cas No. Concentration Solvent Volume 10712.23-K-ME 10712.23-10MG Fluphenazine cis-(z)-flupentixol dihydrochloride cis-(z)-flupentixol dihydrochloride 51529-01-2 1000 µg base/ml methanol 1 ml 51529-01-2 neat neat 10 mg 11163.22-K-ME Fluphenazine dihydrochloride 146-56-5 1000 µg base/ml methanol 1 ml 11163.22-10MG Fluphenazine dihydrochloride 146-56-5 neat neat 10 mg Fluspirilene 9748.29-10MG Fluspirilene 1841-19-6 neat neat 10 mg Haloperidol (Haldol) 10345.21-K-ME Haloperidol 52-86-8 1000 µg/ml methanol 1 ml 10345.21-50MG Haloperidol 52-86-8 neat neat 50 mg 10359.21-100-ME Haloperidol-d4 (4-chlorophenyl-d4) 1189986-59-1 100 µg/ml methanol 1 ml Olanzapine (Zyprexa) 11807.23-K-ME Levomepromazine maleate 7104-38-3 1000 µg base/ml methanol 1 ml 11807.23-10MG Levomepromazine maleate 7104-38-3 neat neat 10 mg 11807.23-50MG Levomepromazine maleate 7104-38-3 neat neat 50 mg Olanzapine (Zyprexa) 3761.17-100-AN Olanzapine 132539-06-1 100 µg/ml acetonitrile 1 ml 3761.17-K-AN Olanzapine 132539-06-1 1000 µg/ml acetonitrile 1 ml 3761.17-10MG Olanzapine 132539-06-1 neat neat 10 mg 3761.17-25MG Olanzapine 132539-06-1 neat neat 25 mg 3761.17-100MG Olanzapine 132539-06-1 neat neat 100 mg 3761.17-250MG Olanzapine 132539-06-1 neat neat 250 mg 3761.17-1G Olanzapine 132539-06-1 neat neat 1 g 9766.17-10-AN Olanzapine-d3 (N-methyl-d3) 786686-79-1 10 µg/ml acetonitrile 1 ml 3924.23-10-ME Olanzapine 10-N-β-D-glucuronide 186792-80-3 10 µg/ml methanol 1 ml 11913.16-K-AN Perphenazine N-Demethylolanzapine (4 -Desmethylolanzapine, Olanzapine Impurity A) 161696-76-0 1000 µg/ml acetonitrile 1 ml 9749.21-10MG Perphenazine 58-39-9 neat neat 10 mg 9914.21-10MG Prochloroperazine Perphenazine-d4 (phenothiazine-1,3,7,9-d4) 155593-75-2 neat neat 10 mg 10856.20-10MG Prochloroperazine maleate 84-02-6 neat neat 10 mg Promazine 11164.17-K-ME Promazine hydrochloride 53-60-1 1000 µg base/ml methanol 1 ml 11164.17-10MG Promazine hydrochloride 53-60-1 neat neat 10 mg www.chiron.no E-mail: sales@chiron.no Tel.: +47 73 87 44 90 Fax.: +47 73 73 87 44 99 BMF 84 p.3/6, 11_16

Catalogue No. Description Cas No. Concentration Solvent Volume 11989.20-K-ME 11989.20-10MG Quetiapine 2-(1-Hydroxypropyl)promazine (10H-Phenothiazine-2-methanol) 2-(1-Hydroxypropyl)promazine (10H-Phenothiazine-2-methanol) 110080-35-8 1000 µg/ml methanol 1 ml 110080-35-8 neat neat 10 mg 10835.21-K-ME Quetiapine hemifumarate 111974-72-2 1000 µg base/ml methanol 1 ml 10835.21-10MG Quetiapine hemifumarate 111974-72-2 neat neat 10 mg Risperidone 10337.23-K-ME Risperidone 106266-06-2 1000 µg/ml methanol 1 ml 10337.23-10MG Risperidone 106266-06-2 neat neat 10 mg 10337.23-25MG Risperidone 106266-06-2 neat neat 25 mg 10338.23-K-ME 10338.23-10MG 10338.23-25MG Thioridazine (+/-)-9-Hydroxyrisperidone (Paliperidone, Risperidone Impurity C) 9-Hydroxyrisperidone (Paliperidone, Risperidone Impurity C) 9-Hydroxyrisperidone (Paliperidone, Risperidone Impurity C) 144598-75-4 1000 µg/ml methanol 1 ml 144598-75-4 neat neat 10 mg 144598-75-4 neat neat 25 mg 11419.21-K-ME Thioridazine hydrochloride 130-61-0 1000 µg base/ml methanol 1 ml Trifluoperazine 11192.21-K-ME Trifluoperazine dihydrochloride 440-17-5 1000 µg base/ml methanol 1 ml 11192.21-10MG Trifluoperazine dihydrochloride 440-17-5 neat neat 10 mg Triflupromazine 11195.18-K-ME 11195.18-10MG Trimipramine Triflupromazine hydrochloride (Trifluopromazine HCl) Triflupromazine hydrochloride (Trifluopromazine HCl) 1098-60-8 1000 µg base/ml methanol 1 ml 1098-60-8 neat neat 10 mg 9415.24-K-ME Trimipramine maleate 521-78-8 1000 µg/ml methanol 1 ml 9415.24-10MG Trimipramine maleate 521-78-8 neat neat 10 mg 9416.24-100-ME 9416.24-10MG Zuclopenthixol Trimipramine-d3 maleate (N-methyl-d3) Trimipramine-d3 maleate (N-methyl-d3) 1185245-93-5 100 µg/ml methanol 1 ml 1185245-93-5 neat neat 10 mg 10284.22-10MG Zuclopenthixol (cis+trans) 982-24-1 neat neat 10 mg 10285.24-10MG Zuclopenthixol acetate (cis+trans) 85721-05-7 neat neat 10 mg 10713.26-1MG cis-(z)-zuclopenthixol succinate 53772-83-1 (free base) neat neat 1 mg 10383.22-1MG cis-(z)-zuclopenthixol-d4 succinate (N-hydroxyethyl-d4) 1246833-97-5 (as trans-isomer) neat neat 1 mg www.chiron.no E-mail: sales@chiron.no Tel.: +47 73 87 44 90 Fax.: +47 73 73 87 44 99 BMF 84 p.4/6, 11_16

Catalogue No. Description Cas No. Concentration Component part Antipsychotic & Antidepressant Mix 7 Compounds at 25 μmol/l (0.025 μmol/ml) (freebase) 10345.21 Haloperidol [52-86-8] 25 µmol/l 3761.17 Olanzapine [132539-06-1] 25µmol/L 11913.16 N-Desmethylolanzapine [161696-76-0] 25 µmol/l 10337.23 Risperidone [106266-06-2] 25 µmol/l 10338.23 9-Hydroxyrisperidone [144598-75-4] 25 µmol/l 9288.17 Mirtazapine [85650-52-8] 25 µmol/l 11189.16 Desmethylmirtazapine hydrochloride [61337-68-6] 25 µmol/l S-4932-0.025uM-ME S-4932-0.025uM-MEx5 1 x 1 ml ampoule 5 x 1 ml ampoules! Chiron AS is an authorised distributor of ACQ Science. Please contact us for information on ACQ Science antipsychotic (Neuroleptic) accuracy controls in serum. www.chiron.no E-mail: sales@chiron.no Tel.: +47 73 87 44 90 Fax.: +47 73 73 87 44 99 BMF 84 p.5/6, 11_16

For ordering and information about prices and delivery in your country, please contact your local distributor: www.chiron.no E-mail: sales@chiron.no Tel.: +47 73 87 44 90 Fax.: +47 73 73 87 44 99 BMF 84 p.6/6, 11_16